The Veteran Overmedication and Suicide Prevention Act of 2025 mandates an independent review of veteran suicides and certain other deaths by the National Academies of Sciences, Engineering, and Medicine. This review will analyze various factors, including prescribed medications, diagnoses, and treatment approaches, to identify patterns and inform updated clinical practice guidelines within the VA. The goal is to improve veteran safety and well-being by addressing potential overmedication and enhancing suicide prevention efforts. A report on the review's findings will be submitted to Congress and made public.
